Management of Disease Modifying Interventions in Alzheimer's
This workshop will serve to discuss the indications and, prescription, and management of adverse events associated with anti-amyloid therapy with monoclonal anti-bodies.
Suzanne Schindler, MD, PhD
Department of Neurology, Washington University School of Medicine
罢补濒办:听Biomarkers for Detection of AD and Indications of Anti-Amyloid Therapy
Abstract: TBD
Alireza Atri, MD, PhD
Department of Neurology, Harvard Medical School
罢补濒办:听Amyloid Related Imaging Abnormalities (ARIA)
Abstract: TBD
听
Programme
Tuesday, December 3, 2024
| 13:00 |
Welcome &听Opening Remarks Pedro Rosa-Neto, MD, PhD, The Douglas Research Centre, 污污草莓视频 University Moderator:听Serge Gauthier, MD,听The Douglas Research Centre, 污污草莓视频 University |
| 13:10 |
Disease Modify Interventions in AD in Canada TBA |
| 14:00 |
Biomarkers for Detection of AD and Indications of Anti-Amyloid Therapy Suzanne Schindler, MD, PhD,听Knight Alzheimer Disease Research Center,听Washington University School of Medicine in St. Louis |
| 14:45 | Refreshment Pause |
| 15:15 |
Amyloid Related Imaging Abnormalities (ARIA) Alireza Atri, MD, PhD,听Banner Sun Health Research Institute,听Harvard Medical School |
| 16:00 |
Closing Remarks Pedro Rosa-Neto, MD, PhD, The Douglas Research Centre, 污污草莓视频 University |
| 16:15 | Cocktail & Networking |
Sponsors
Organizing Committee
Pedro Rosa-Neto
Director, Translational Neuroimaging Laboratory, Douglas Research Centre
Debbie Rashcovsky
Neuro Events Team Lead
